US Stock MarketDetailed Quotes

NAVB Navidea Biopharmaceuticals

Watchlist
  • 0.001
  • 0.0000.00%
15min DelayClose Oct 29 16:00 ET
100.08KMarket Cap-12P/E (TTM)

Navidea Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Navidea Biopharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Nov 10, 20212021/Q396.380K / 0.000--
Aug 11, 20212021/Q2261.050K / 600.000K--
May 11, 20212021/Q1123.740K / 600.000K--
Mar 24, 20212020/Q4219.250K / 300.000K--
Nov 12, 20202020/Q3268.390K / 150.000K--
DatePeriodRevenue/EstimateEarnings Call
Nov 10, 20212021/Q396.380K / 0.000--
Aug 11, 20212021/Q2261.050K / 600.000K--
May 11, 20212021/Q1123.740K / 600.000K--
Mar 24, 20212020/Q4219.250K / 300.000K--
Nov 12, 20202020/Q3268.390K / 150.000K--

Unlock Free Earnings Estimates

Navidea Biopharmaceuticals Earnings Reports

  • Navidea Biopharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 14, 2023 17:21 ET

  • Navidea Biopharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 11, 2023 16:06 ET

  • Navidea Biopharmaceuticals | 10-Q: Q1 2023 Earnings Report

    May 11, 2023 16:56 ET

  • Navidea Biopharmaceuticals | 10-K: FY2022 Annual Report

    Mar 27, 2023 16:31 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data